Nuvation Bio Inc. Files 8-K on Shareholder Vote Matters
Ticker: NUVB · Form: 8-K · Filed: May 23, 2025 · CIK: 1811063
Sentiment: neutral
Topics: shareholder-vote, corporate-governance, filing
Related Tickers: NUVO
TL;DR
NUVO filed an 8-K for a shareholder vote on 5/21. Expect updates soon.
AI Summary
Nuvation Bio Inc. filed an 8-K on May 23, 2025, reporting on a submission of matters to a vote of security holders that occurred on May 21, 2025. The company, formerly known as Panacea Acquisition Corp. until April 30, 2020, is incorporated in Delaware and headquartered in San Francisco, CA.
Why It Matters
This filing indicates that Nuvation Bio Inc. is engaging its shareholders on important corporate decisions, which could impact the company's strategic direction and shareholder rights.
Risk Assessment
Risk Level: low — The filing is a routine disclosure of a shareholder vote, not indicating any immediate financial distress or significant operational change.
Key Players & Entities
- Nuvation Bio Inc. (company) — Registrant
- Panacea Acquisition Corp. (company) — Former company name
- May 21, 2025 (date) — Earliest event reported
- May 23, 2025 (date) — Date of report
- Delaware (jurisdiction) — State of incorporation
FAQ
What specific matters were submitted for a vote of security holders on May 21, 2025?
The filing states that matters were submitted to a vote of security holders, but the specific details of these matters are not provided in the provided text.
When did Nuvation Bio Inc. change its name from Panacea Acquisition Corp.?
Nuvation Bio Inc. changed its name from Panacea Acquisition Corp. on April 30, 2020.
What is Nuvation Bio Inc.'s principal executive office address?
Nuvation Bio Inc.'s principal executive offices are located at 1500 Broadway, Suite 1401, New York, NY 10036.
What is the SIC code for Nuvation Bio Inc.?
The Standard Industrial Classification (SIC) code for Nuvation Bio Inc. is 2834, which corresponds to Pharmaceutical Preparations.
What is the fiscal year end for Nuvation Bio Inc.?
Nuvation Bio Inc.'s fiscal year ends on December 31.
Filing Details
This Form 8-K (Form 8-K) was filed with the SEC on May 23, 2025 regarding Nuvation Bio Inc. (NUVB).